The long term goal of this research program continues to be the understanding of mechanisms by which GABA-A receptor expression is regulated and the contribution of individual subunit proteins to receptor function. This includes analysis of the role of the receptor subunits in mediating the physiologic effects of benzodiazepines and barbiturates. Gamma-Aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the central nervous system. A substantial portion of the inhibitory actions of GABA are achieved via the GABA-A receptors. The GABA-A receptors appear to be constituted of 5 subunit proteins that are the products of transcription, alternative splicing and translation of at least 16 different genes. Each specific combination of these subunit proteins results in a receptor complex with subtly different characteristics in terms of the chloride conductance which GABA elicits and the modulatory influences of benzodiazepines, barbiturates, and steroids on these receptors. During years 17 through 20 of this research program, we propose to focus on four major hypotheses related to the regulation of GABA-A receptor structure and function, as well as its role in development. First, we will test the hypothesis that GABA-A subunit expression is regulated by metabotropic acidic amino acid/peptide receptors. Based on data obtained during the previous support interval, we propose that activation of metabotropic receptors by NAAG and other agonists influences alpha6 GABA-A receptor subunit expression in cerebellar granule cells. Subunit mRNA and protein expression will be examined in granule cell cultures using PCR and immunoblot methods. We will continue to develop subunit specific (alpha6, gamma2, beta2) antibodies which will be used to confirm subunit protein expression. Second, we will test the hypothesis that phosphorylation of the GABA-A receptors is influenced by the balance of excitatory and inhibitory receptor activation. We will use cerebellar granule cells in culture to define the extent of subunit phosphorylation under conditions of activation and blockade of GABA-A and 'glutamate' receptors. Third, we will test the hypothesis that individual neurons with similar structure and position in the CNS express different subsets of GABA-A receptor subunit mRNA and that these differences result in distinguishable electrophysiological responses to GABA, benzodiazepines and barbiturates. We have succeeded in identifying the mRNA for two different GABA-A subunit proteins in single cells in which the GABA-A receptor responses have been characterized under patch clamp conditions. We propose to extend this approach to the preparation of mRNA libraries from individual, electrophysiologically characterized cells. This technically demanding approach will permit us to test in primary cell culture and in brain slices, a series of hypotheses, derived from transfection studies, on the function of GABA-A subunit proteins in situ. Additionally, this work may confirm and perhaps extend hypotheses on preferential subunit association in GABA-A receptors that have been derived from in situ hybridization and transfection studies. Fourth, we will test the hypothesis that GABA-A receptors contribute to the establishing patterns of synaptic connectivity in the developing central nervous system. Rapidly, evolving transgenic methods will be applied to produce null mutations of the alpha6 and gamma2 subunit genes and conditional deletions of the alpha1 and beta2 subunit expression via the controlled expressions of ribozymes targeted for subunit transcripts.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002297-18
Application #
2443394
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1979-04-01
Project End
2000-06-30
Budget Start
1997-07-15
Budget End
1998-06-30
Support Year
18
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Georgetown University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Potter, Jennifer Sharpe; Dreifuss, Jessica A; Marino, Elise N et al. (2015) The multi-site prescription opioid addiction treatment study: 18-month outcomes. J Subst Abuse Treat 48:62-9
Weiss, Roger D; Potter, Jennifer Sharpe; Griffin, Margaret L et al. (2014) Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat 47:140-5
Griffin, Margaret L; Dodd, Dorian R; Potter, Jennifer S et al. (2014) Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse 40:157-62
Sharpe Potter, Jennifer; Bebarta, Vikhyat S; Marino, Elise N et al. (2014) Pain management and opioid risk mitigation in the military. Mil Med 179:553-8
Potter, Jennifer Sharpe; Marino, Elise N (2013) How to avoid opioid misuse. J Fam Pract 62:S2-7
Fiszman, M L; Borodinsky, L N; Neale, J H (1999) GABA induces proliferation of immature cerebellar granule cells grown in vitro. Brain Res Dev Brain Res 115:1-8
Borodinsky, L N; Fiszman, M L (1998) Extracellular potassium concentration regulates proliferation of immature cerebellar granule cells. Brain Res Dev Brain Res 107:43-8
Charlton, M E; Sweetnam, P M; Fitzgerald, L W et al. (1997) Chronic ethanol administration regulates the expression of GABAA receptor alpha 1 and alpha 5 subunits in the ventral tegmental area and hippocampus. J Neurochem 68:121-7
Ghose, S; Wroblewska, B; Corsi, L et al. (1997) N-acetylaspartylglutamate stimulates metabotropic glutamate receptor 3 to regulate expression of the GABA(A) alpha6 subunit in cerebellar granule cells. J Neurochem 69:2326-35
Tieman, S B; Tieman, D G (1996) N-acetylaspartylglutamate immunoreactivity in human retina. Vision Res 36:941-7

Showing the most recent 10 out of 35 publications